Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18:56–66. https://doi.org/10.1038/s41575-020-00360-x.

Article  PubMed  Google Scholar 

Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13:e065186. https://doi.org/10.1136/bmjopen-2022-065186.

Article  PubMed  PubMed Central  Google Scholar 

Soloway M, Moir TW, Linton DS Jr. Takayasuʼs arteritis. Report of a case with unusual findings. Am J Cardiol. 1970;25:258–63. https://doi.org/10.1016/0002-9149(70)90588-6.

Article  CAS  PubMed  Google Scholar 

Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155–65. https://doi.org/10.1016/j.mayocp.2018.09.013.

Article  CAS  PubMed  Google Scholar 

de Almeida Martins C, Caon AER, Facanali CBG, Sobrado CW, Nahas SC, Pereira RMR, Margalit-Yehuda R, Kopylov U, Queiroz NSF. Coexistence of Takayasuʼs arteritis in patients with inflammatory bowel diseases. Gastroenterol Res Pract. 2021;2021:8831867. https://doi.org/10.1155/2021/8831867.eCollection2021.

Article  PubMed  PubMed Central  Google Scholar 

Esatoglu SN, Ok AM, Ucar D, Celik AF, Ugurlu S, Hamuryudan V, Yazici H, Seyahi E. Takayasuʼs arteritis: associated inflammatory diseases. Clin Exp Rheumatol. 2020;38(Suppl 124):61–8.

PubMed  Google Scholar 

Guarino AD, Testa A, Mormile I, Imperatore N, Granata F, Rispo A, De Paulis A, Castiglione F. Crohnʼs disease and Takayasuʼs arteritis: are they associated? Eur Rev Med Pharmacol Sci. 2021;25:1472–84. https://doi.org/10.26355/eurrev_202102_24855.

Article  CAS  PubMed  Google Scholar 

Iba Ba J, Mfoumou AF, Mbounja M, Lédaga Lentombo L, Kombila UD, Igala M, Boguikouma JB. A rare association of Takayasuʼs disease and inflammatory bowel disease in GabonMed Trop Sante Int. 2023;3:mtsi.v3i3.2023.386. https://doi.org/10.48327/mtsi.v3i3.2023.386.

Takahashi N, Tanabe K, Sugamori T, Sato M, Kitamura J, Sato H, Yoshitomi H, Ishibashi Y, Shimada T. Association between Takayasu arteritis and ulcerative colitis - case report and review of serological HLA analysis. Med Sci Monit. 2011;17:CS81-84. https://doi.org/10.12659/msm.881837.

Article  PubMed  PubMed Central  Google Scholar 

Akiyama S, Fujii T, Matsuoka K, Yusuke E, Negi M, Takenaka K, Nagahori M, Ohtsuka K, Isobe M, Watanabe M. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32:1011–7. https://doi.org/10.1111/jgh.13640.

Article  CAS  PubMed  Google Scholar 

Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226–32. https://doi.org/10.1002/art.39157.

Article  PubMed  Google Scholar 

Kanitez NA, Toz B, Gulluoglu M, Erer B, Esen BA, Omma A, Sahinkaya Y, Iliaz R, Cavus B, Gul A, et al. Microscopic colitis in patients with Takayasuʼs arteritis: a potential association between the two disease entities. Clin Rheumatol. 2016;35:2495–9. https://doi.org/10.1007/s10067-015-3149-x.

Article  PubMed  Google Scholar 

Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7. https://doi.org/10.7554/eLife.34408.

Renauer PA, Saruhan-Direskeneli G, Coit P, Adler A, Aksu K, Keser G, Alibaz-Oner F, Aydin SZ, Kamali S, Inanc M, et al. Identification of susceptibility Loci in IL6, RPS9/LILRB3, and an intergenic locus on Chromosome 21q22 in Takayasu arteritis in a genome-wide association study. Arthritis Rheumatol. 2015;67:1361–8. https://doi.org/10.1002/art.39035.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–86. https://doi.org/10.1038/ng.3359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497–501. https://doi.org/10.1093/ije/dyt179.

Article  PubMed  Google Scholar 

Savioli B, Abdulahad WH, Brouwer E, Kallenberg CGM, de Souza AWS. Are cytokines and chemokines suitable biomarkers for Takayasu arteritis? Autoimmun Rev. 2017;16:1071–8. https://doi.org/10.1016/j.autrev.2017.07.023.

Article  CAS  PubMed  Google Scholar 

Misra DP, Singh K, Sharma A, Agarwal V. Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation. Front Immunol. 2023;14:1174249. https://doi.org/10.3389/fimmu.2023.1174249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueno A, Jeffery L, Kobayashi T, Hibi T, Ghosh S, Jijon H. Th17 plasticity and its relevance to inflammatory bowel disease. J Autoimmun. 2018;87:38–49. https://doi.org/10.1016/j.jaut.2017.12.004.

Article  CAS  PubMed  Google Scholar 

Minami N, Nakase H, Yoshino T, Yamada S, Toyonaga T, Honzawa Y, Matsuura M, Chiba T. Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature. Clin J Gastroenterol. 2013;6:226–30. https://doi.org/10.1007/s12328-013-0387-9.

Article  PubMed  Google Scholar 

Ratuapli S, Mazlumzadeh M, Gurudu S, Money S, Heigh R. Coexisting Crohnʼs disease and Takayasuʼs arteritis in two patients treated with anti-TNF-alpha therapies. Case Rep Gastroenterol. 2010;4:35–40. https://doi.org/10.1159/000270919.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamali S, Inanc M, Carette S, et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013;93:298–305. https://doi.org/10.1016/j.ajhg.2013.05.026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terao C, Yoshifuji H, Nakajima T, Yukawa N, Matsuda F, Mimori T. Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application. Scand J Rheumatol. 2016;45:80–2. https://doi.org/10.3109/03009742.2015.1060521.

Article  CAS  PubMed  Google Scholar 

Amre DK, Mack DR, Morgan K, Fujiwara M, Israel D, Deslandres C, Seidman EG, Lambrette P, Costea I, Krupoves A, et al. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohnʼs disease in Canadian children. Am J Gastroenterol. 2009;104:2824–8. https://doi.org/10.1038/ajg.2009.430.

Article  CAS  PubMed  Google Scholar 

Wang J, Liu H, Wang Y, Wu J, Wang C, Liu K, Qin Q. The polymorphisms of Interleukin-12B gene and susceptibility to inflammatory bowel diseases: a meta-analysis and trial sequential analysis. Immunol Invest. 2021;50:987–1006. https://doi.org/10.1080/08820139.2020.1863981.

Article  CAS  PubMed  Google Scholar 

Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol. 2020;55:4–14. https://doi.org/10.1007/s00535-019-01618-1.

Article  PubMed  Google Scholar 

Krupa WM, Dewan M, Jeon MS, Kurtin PJ, Younge BR, Goronzy JJ, Weyand CM. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol. 2002;161:1815–23. https://doi.org/10.1016/S0002-9440(10)64458-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69. https://doi.org/10.1038/nri2448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425–40. https://doi.org/10.1002/jcp.26429.

Article  CAS  PubMed  Google Scholar 

Michailidou D, Kuley R, Wang T, Hermanson P, Grayson PC, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, et al. Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis. Clin Immunol. 2023;249:109274. https://doi.org/10.1016/j.clim.2023.109274.

Article  CAS  PubMed  Google Scholar 

Saadoun D, Vautier M, Cacoub P. Medium- and large-vessel vasculitis. Circulation. 2021;143:267–82. https://doi.org/10.1161/CIRCULATIONAHA.120.046657.

Article  CAS  PubMed  Google Scholar 

Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, Okumura K, Sato O, Takagi A, Tada Y, et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu’s arteritis. J Clin Invest. 1994;93:750–8. https://doi.org/10.1172/JCI117029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren YL, Li TT, Cui W, Zhao LM, Gao N, Liao H, Zhang JH, Zhu JM, Qiao ZY, Guo SC, et al. CD8(+) T lymphocyte is a main source of interferon-gamma production in Takayasu’s arteritis. Sci Rep. 2021;11:17111. https://doi.org/10.1038/s41598-021-96632-w.

Article  CAS  PubMed